What Happens If You Fail a Nuclear Stress Test?

An abnormal nuclear stress test means the images showed at least one area of your heart muscle that did not receive as much blood flow during stress as it did at rest, or that a region of your heart appears permanently under-supplied. In one quality-initiative study, only about half of patients who had an abnormal stress test turned out to have obstructive coronary artery disease when they went on to cardiac catheterization.¹ That number alone tells you something important: a “failed” nuclear stress test is a signal that warrants investigation, not an automatic sentence of heart disease.

What “Failing” a Nuclear Stress Test Actually Looks Like

Doctors do not literally grade a nuclear stress test as pass or fail the way a school exam is graded. What they look for is whether the radioactive tracer taken up by your heart muscle during exercise or pharmacological stress matches the pattern seen at rest. When the images look the same under both conditions, the test is considered normal. When they do not, cardiologists categorize the mismatch in ways that guide the next steps.

A “reversible defect” is the classic red flag. It means a section of the heart got less blood flow during stress than at rest, suggesting that a coronary artery supplying that area cannot keep up with demand. This pattern raises concern for significant narrowing somewhere upstream. A “fixed defect,” on the other hand, shows reduced blood flow in the same spot both at rest and under stress. That pattern usually points to scar tissue from a prior heart attack or, in some cases, permanently damaged muscle. Research on thallium imaging found that after revascularization, about 79% of regions with reversible defects recovered normal contraction, compared with only 30% of regions that had mild-to-moderate fixed defects.² In other words, whether the abnormality is reversible or fixed has real implications for what can be done about it and how well the heart might recover.

The size and severity of the defect matter, too. A small area of mildly reduced tracer uptake is very different from a large swath of the heart muscle showing almost no uptake under stress. Cardiologists often quantify the extent and severity using scoring systems, and those numbers feed directly into the conversation about risk and next steps.

Why an Abnormal Result Does Not Always Mean Blocked Arteries

One of the most common misunderstandings after an abnormal nuclear stress test is the assumption that the coronary arteries must be severely narrowed. In reality, the images can look abnormal for reasons that have nothing to do with plaque buildup in the large arteries. That roughly 50% figure from catheterization studies is not an outlier; it reflects a genuine limitation of the technology.¹

Attenuation artifacts are one of the biggest culprits behind false positive results. These occur when body tissue between the heart and the camera absorbs some of the radioactive signal, making a healthy area of the heart look under-perfused. Breast tissue is the most frequent cause of false positive results in women undergoing SPECT imaging.³ In both men and women, the diaphragm can also create artifacts along the bottom wall of the heart, especially in patients with larger body habitus or those who take shallow breaths during imaging.⁴ An experienced nuclear cardiologist will try to distinguish artifacts from real perfusion problems, but the distinction is not always clean-cut, which is why follow-up testing exists.

Coronary microvascular dysfunction is another reason a stress test can come back abnormal even when the main coronary arteries are wide open. In this condition, the tiny blood vessels deep in the heart muscle do not dilate properly under stress, producing a picture that can look a lot like obstructive disease. One study examining patients who had positive stress tests but no obstructive disease on angiography found that when microvascular function was formally assessed, the apparent “false positive” rate of the stress test essentially dropped to zero, because those patients genuinely had a vascular problem, just not in the large arteries.⁵ The stress test was picking up a real problem; cardiologists had simply been looking in the wrong place for the cause.

What Happens Next After an Abnormal Result

If your nuclear stress test is abnormal, the next conversation with your cardiologist will center on how abnormal, how symptomatic you are, and what your overall risk profile looks like. The pathway is not one-size-fits-all.

For many patients, especially those with a moderately abnormal result and ongoing symptoms, the traditional next step has been an invasive coronary angiogram, also called cardiac catheterization. A catheter is threaded through a blood vessel to the heart and dye is injected so the arteries can be visualized directly. This is still the gold standard for identifying blockages, and if a significant narrowing is found during the procedure, it can sometimes be treated on the spot with a stent.

A less invasive alternative has gained ground in recent years. Coronary CT angiography uses a specialized CT scan to create detailed images of the coronary arteries without threading a catheter into the heart. A large multicenter registry found a strong association between CT angiography results and the findings at subsequent invasive catheterization, suggesting CT angiography can serve as an effective filter, sparing some patients from the catheter altogether.⁶ If the CT scan shows clean arteries, the catheterization may be safely deferred. If it confirms a suspicious lesion, the invasive procedure can proceed with greater confidence that the patient will benefit.

In cases where the abnormality is small or the clinical picture is less alarming, the cardiologist may recommend medical management and close follow-up rather than rushing to catheterization. This is not a brush-off; as the next section explains, the evidence on this point is stronger than many patients expect.

The Surprising Evidence on Medical Therapy Versus Procedures

For decades, the instinct after an abnormal stress test was to find the blockage and fix it, often with a stent or bypass surgery. The assumption was that opening a narrowed artery would prevent heart attacks and save lives. That assumption took a serious hit with the ISCHEMIA trial, one of the largest studies ever conducted on this question.

The ISCHEMIA trial enrolled patients with stable coronary disease and at least moderate ischemia on stress testing and randomly assigned them to either an early invasive strategy (angiography and revascularization as appropriate, plus medications) or a conservative strategy (medications alone, with catheterization reserved only for patients whose symptoms became unmanageable). Over a median follow-up of about three years, there was no significant difference in death or major cardiovascular events between the two groups.⁷ The invasive group actually had a slightly higher event rate early on, driven by procedure-related heart-muscle damage, while the conservative group caught up over several years. By five years the rates were essentially even.⁸

What the invasive approach did improve was symptom burden. Patients who got stents or bypass surgery reported less chest pain and better quality of life, particularly in the first couple of years. So for someone whose daily life is significantly limited by angina, revascularization still makes sense. But for patients whose symptoms are manageable, a careful program of medications, including anti-platelet agents, statins, blood pressure control, and lifestyle modification, produces survival outcomes that are statistically indistinguishable from jumping straight to a procedure.⁹

This is genuinely reassuring if you have failed a nuclear stress test but are not having disabling symptoms. The evidence suggests you have time to start on optimal medical therapy and see how things go, rather than feeling that you need an emergency catheterization. Of course, this applies to stable disease. If you are having a heart attack or rapidly worsening unstable angina, the calculus is entirely different, and prompt intervention remains essential.

When the Stress Test Misses the Problem Entirely

The flip side of false positives is false negatives, and nuclear stress tests have a specific blind spot worth knowing about. It is called balanced ischemia. Because the test works by comparing blood flow between different regions of the heart, it relies on at least one region looking relatively normal to serve as the reference point. When all three main coronary arteries are severely narrowed to a similar degree, every part of the heart is equally starved during stress, and the resulting images can appear deceptively uniform and normal.¹⁰

Case reports have documented patients with triple-vessel coronary artery disease whose SPECT images showed no perfusion defects at all, even as their exercise ECGs were markedly abnormal.¹¹ These patients have some of the most dangerous forms of heart disease, yet their nuclear imaging looks reassuring. Balanced ischemia is an important consideration when interpreting perfusion imaging results, particularly in patients with a high pre-test probability of multivessel disease.¹²

This matters for you because a normal nuclear stress test, while generally reassuring, does not guarantee your arteries are clean. If you have significant risk factors, persistent symptoms, or other red flags, your doctor may still pursue further testing despite a normal scan. Conversely, the existence of this blind spot reinforces that clinical context, not just the scan alone, drives good decision-making.

Why Stress Test Results Can Be Different for Women

Women face a particular set of challenges when it comes to nuclear stress testing. Coronary microvascular dysfunction, the condition where the small vessels of the heart fail to dilate properly, has been detected in up to half of women presenting with chest pain who turn out to have clean-looking large arteries on angiography.¹³ Women with this condition are not imagining their symptoms; research shows they face a real increase in future cardiovascular events.¹³ But because standard catheterization only looks at the large arteries, these patients have historically been told their hearts are fine and sent home without treatment.

Adding to the diagnostic complexity, breast attenuation artifacts are more common in women, as noted earlier, which can produce false positive results and lead to unnecessary downstream procedures.³ So women are simultaneously at higher risk of getting a false alarm from an artifact and at higher risk of having a real vascular problem that is difficult to pin down with conventional testing. One study examining patients with angina but no obstructive coronary disease found that women made up more than three-quarters of the study population, and endothelial dysfunction was present in nearly two-thirds of participants.¹⁴

If you are a woman who has failed a nuclear stress test and then been told your catheterization looks normal, it is worth asking your cardiologist specifically about microvascular dysfunction. Specialized invasive testing using coronary reactivity assessment is considered the gold standard for diagnosing it, and treatment strategies do exist even though they differ from the standard stent-or-bypass approach.

PET Versus SPECT and How Imaging Choice Affects Your Results

Not all nuclear stress tests are created equal, and the type of imaging your facility uses can influence both the accuracy of your results and the testing cascade that follows. The two main technologies are SPECT (single photon emission computed tomography) and PET (positron emission tomography). SPECT is far more widely available and has been the workhorse of nuclear cardiology for decades. PET is newer, more expensive, and typically found at larger medical centers.

A systematic review of the evidence found that PET had the highest diagnostic value for coronary artery disease among the nuclear imaging modalities studied, and was particularly better at detecting disease involving multiple vessels.¹⁵ PET’s superior resolution also means fewer of the attenuation artifacts that plague SPECT, which is especially relevant for larger patients and women.

This accuracy difference has practical downstream consequences. A propensity-matched analysis comparing patients who had PET versus SPECT found that those in the PET group were slightly less likely to undergo invasive catheterization within 90 days, but when catheterization did happen, a higher proportion led to an actual stent placement. In numbers, about 6% of PET patients went on to catheterization compared with nearly 7% of SPECT patients, while the rate of stent placement after PET was roughly double that after SPECT.¹⁶ The interpretation here is that PET, by being more accurate upfront, sends fewer patients into unnecessary catheterizations while catching more patients who genuinely need intervention. If you have access to a facility that offers cardiac PET, particularly if prior SPECT results have been ambiguous, it may be worth discussing with your cardiologist.

What an Abnormal Test Means Before Surgery

One specific scenario where a nuclear stress test is commonly ordered is before a major non-cardiac surgery. If you need a hip replacement, a big abdominal operation, or vascular surgery, your surgical team may want to know whether your heart can handle the physiological stress of the procedure. Failing a preoperative nuclear stress test in this context carries particular weight.

A study of elderly patients undergoing preoperative nuclear stress testing found that those with an abnormal result were about six times more likely to suffer a major adverse cardiac event around the time of surgery compared with those who tested normal.¹⁷ That is a large enough difference in risk that it can change surgical planning. It might mean additional cardiac workup before proceeding, modification of the surgical approach, enhanced perioperative monitoring, or in some cases a decision that the risks of the planned surgery outweigh the benefits.

It does not necessarily mean the surgery is canceled. The abnormal stress test provides a risk estimate that the surgical and anesthesia teams factor into the overall plan. In many cases, the surgery still goes forward, but with precautions in place that would not have been taken had the test been normal. Knowing about the cardiac risk ahead of time is precisely the point of ordering the test.

Pharmacological Versus Exercise Stress

The “stress” in a nuclear stress test can come from walking on a treadmill, pedaling a stationary bike, or receiving a medication that mimics the effect of exercise on the heart. If you cannot exercise to an adequate level due to joint problems, deconditioning, or other limitations, your test will likely use a pharmacological agent. Regadenoson is one of the most commonly used drugs for this purpose, and a phase 3 trial showed it was at least as good as the older agent adenosine at detecting reversible ischemia, with a simpler dosing protocol and generally better tolerability.

The choice between exercise and pharmacological stress can subtly affect the information your cardiologist gets. Exercise testing provides additional data beyond the images: how long you can exercise, how your blood pressure responds, whether you develop abnormal heart rhythms, and whether you experience chest pain during exertion. All of this has independent prognostic value. A pharmacological test gives you the images but not that exercise capacity data. Neither approach is wrong, but if you are physically able to exercise, your cardiologist will usually prefer that you do, because the extra information helps paint a fuller picture of your cardiac health. The nuclear images themselves are interpreted the same way regardless of how the stress was induced.

Lifestyle Changes That Matter Whether or Not You Get a Procedure

Regardless of whether your abnormal stress test leads to a catheterization, a stent, bypass surgery, or simply a prescription for medications, the lifestyle component of management is the same and genuinely matters. The medications proven to reduce cardiovascular events in patients with coronary disease, statins, blood pressure medications, and anti-platelet agents, all work better when paired with changes in diet, physical activity, smoking cessation, and weight management.

Cardiac rehabilitation programs, which combine supervised exercise with education on risk factor management, are specifically designed for this situation. They are recommended for patients after heart events and revascularization, but they can also benefit patients with stable disease managed conservatively. The exercise component improves both cardiovascular fitness and the heart’s ability to cope with stress, which is exactly what the nuclear stress test was measuring in the first place.

If you have failed a nuclear stress test, the single most productive thing you can do while waiting for further workup is to talk frankly with your doctor about which modifiable risk factors you can start addressing immediately. Smoking cessation, if relevant, has a larger effect on your long-term cardiac risk than nearly any procedure or pill. Dietary changes and regular moderate exercise contribute meaningfully as well. These are not consolation prizes handed out instead of “real” treatment. The ISCHEMIA trial data show they form the backbone of what keeps people with stable coronary disease alive and well, whether or not a stent is also in the picture.